migalastat has been researched along with n-nonyl-1-deoxynojirimycin in 1 studies
Studies (migalastat) | Trials (migalastat) | Recent Studies (post-2010) (migalastat) | Studies (n-nonyl-1-deoxynojirimycin) | Trials (n-nonyl-1-deoxynojirimycin) | Recent Studies (post-2010) (n-nonyl-1-deoxynojirimycin) |
---|---|---|---|---|---|
143 | 14 | 89 | 37 | 1 | 21 |
Protein | Taxonomy | migalastat (IC50) | n-nonyl-1-deoxynojirimycin (IC50) |
---|---|---|---|
Sucrase-isomaltase | Mus musculus (house mouse) | 0.4 | |
Ceramide glucosyltransferase | Mus musculus (house mouse) | 4 | |
Lysosomal acid glucosylceramidase | Homo sapiens (human) | 1.2639 | |
Protein-lysine 6-oxidase | Homo sapiens (human) | 1.5 | |
Lysosomal alpha-glucosidase | Mus musculus (house mouse) | 8 | |
Non-lysosomal glucosylceramidase | Homo sapiens (human) | 0.005 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA | 1 |
1 review(s) available for migalastat and n-nonyl-1-deoxynojirimycin
Article | Year |
---|---|
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship | 2013 |